Evidence map›Paper›PMID 19414794›Full record

ArticleJournal of immunology (Baltimore, Md. : 1950)2009

Impaired priming and activation of the neutrophil NADPH oxidase in patients with IRAK4 or NEMO deficiency.

Anjali Singh, Kol A Zarember, Douglas B Kuhns, John I Gallin

Open access · bronzeAbstract read
In one paragraph

Article in Journal of immunology (Baltimore, Md. : 1950), 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
2.6field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 49 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. β-hydroxybutyrate impairs monocyte functionFrontiers in veterinary science · 2022
    Article
  5. Immunity toMicrobiology spectrum · 2019
    Review
  6. Article
  7. Article
  8. Article
  9. Macrophage-derived IL-1β enhances monosodium urate crystal-triggered NET formation.Inflammation research : official journal of the European Histamine Research Society ... [et al.] · 2017
    Article
  10. Article
  11. Review
  12. The multifaceted functions of neutrophils.Annual review of pathology · 2014
    Review
  13. Neutropenia in primary immunodeficiency.Current opinion in hematology · 2013
    Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

Anjali SinghLaboratory of Host Defenses, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892-1504, USA.
Kol A Zarember
Douglas B Kuhns
John I Gallin
National Institutes of Health · USNational Cancer Institute · US

Funding

Clinical Studies Of Abnormal Host DefenseZIAAI000155 · NIAID · NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES · PI GALLIN, JOHN I · 2009 to 2022
$3.1M
Effect Of Cytokines In Host Defense And InflammationZIAAI000521 · NIAID · NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES · PI GALLIN, JOHN I · 2009 to 2015
$1.1M
EFFECT OF CYTOKINES IN HOST DEFENSE AND INFLAMMATIONZ01AI000521 · NIAID · NIAID EXTRAMURAL ACTIVITIES · PI GALLIN, JOHN I · 1988 to 2008
$505k
PHAGOCYTIC CELL FUNCTIONZ01AI000155 · NIAID · NIAID EXTRAMURAL ACTIVITIES · PI GALLIN, JOHN I · 1985 to 2008
$404k
Intramural NIH HHS Z01 AI000155Intramural NIH HHS Z01 AI000521Intramural NIH HHS ZIA AI000155Intramural NIH HHS ZIA AI000521
6 · The paper itself

Abstract

The NADPH oxidase (NOX), an oligomeric enzyme, plays a key role in polymorphonuclear neutrophil (PMN)-mediated host defense by producing cytotoxic superoxide anion (O(2)( )). Whereas in vitro and biochemical studies have examined the assembly and activation of this important host immune defense system, few studies have examined the function of NOX in human patients with primary immunodeficiency other than chronic granulomatous disease. We studied the activation of NOX in PMN from patients with two distinct immunodeficiencies, IL-1R-associated kinase (IRAK)4 deficiency and NF-kappaB essential modulator (NEMO or IkappaB kinase gamma) deficiency. We observed impaired O(2)( ) generation by LPS-treated and fMLP-activated IRAK4-deficient PMN that correlated with decreased phosphorylation of p47(phox) and subnormal translocation of p47(phox), p67(phox), Rac2, and gp91(phox)/Nox2 to the membranes indicating that TLR4 signaling to the NOX activation pathway requires IRAK4. NEMO-deficient PMN generated significantly less O(2)( ) in response to LPS-primed fMLP and translocated less p67(phox) than normal PMN, although p47(phox) and Rac2 translocation were normal. Generally, responses of NEMO-deficient cells were intermediate between IRAK4-deficient cells and normal cells. Decreased LPS- and fMLP-induced phosphorylation of p38 MAPK in both IRAK4- and NEMO-deficient PMN implicates additional signal transduction pathways in regulating PMN activation by LPS and fMLP. Decreased activation of NOX may contribute to the increased risk of infection seen in patients with IRAK4 and NEMO deficiency.

Indexed as

Common Variable ImmunodeficiencyEnzyme ActivationHumansI-kappa B KinaseInterleukin-1 Receptor-Associated KinasesNADPH OxidasesNeutrophilsSignal TransductionI-kappa B KinaseIKBKG protein, humanInterleukin-1 Receptor-Associated KinasesIRAK4 protein, humanNADPH Oxidases

Identifiers

PMID19414794
PMCPMC3733113
OpenAlexW1498346321

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.